Literature DB >> 21663380

Association between the MTHFR gene and Alzheimer's disease: a meta-analysis.

Ye Hua1, Hui Zhao, Yuenan Kong, Min Ye.   

Abstract

BACKGROUND: The association between methylenetetrahydrofolate reductase (MTHFR) gene (rs1801133) 677C/T polymorphism and Alzheimer's disease (AD) is controversial. The objective of the study was to investigate the possible association between MTHFR 677C/T polymorphism and AD.
METHOD: We performed a meta-analysis pooling data from all relevant studies including 3,299 cases and 4,363 controls. We applied a random-effects or fixed-effects model to combine odds ratio (OR) and 95% confidence intervals (95% CI).
RESULTS: This meta-analysis demonstrated that the MTHFR T allele or dominant model for T allele (CT + TT) had an increased risk for AD in combined populations (OR, 95% CI: 1.13, 1.05-1.21; 1.18, 1.07-1.31, respectively), and a significant association was found in allele contrast, recessive, and dominant model in Asian populations, but not in Caucasian populations.
CONCLUSION: The MTHFR C677T polymorphism is associated with AD in Asian populations, but not in Caucasians.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21663380     DOI: 10.3109/00207454.2011.578778

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  22 in total

Review 1.  Folate and Alzheimer: when time matters.

Authors:  Margareta Hinterberger; Peter Fischer
Journal:  J Neural Transm (Vienna)       Date:  2012-05-25       Impact factor: 3.575

Review 2.  Power failure: why small sample size undermines the reliability of neuroscience.

Authors:  Katherine S Button; John P A Ioannidis; Claire Mokrysz; Brian A Nosek; Jonathan Flint; Emma S J Robinson; Marcus R Munafò
Journal:  Nat Rev Neurosci       Date:  2013-04-10       Impact factor: 34.870

3.  Association of MTHFR and PICALM polymorphisms with Alzheimer's disease.

Authors:  Luciano Belcavello; Daniela Camporez; Leila D Almeida; Renato L Morelato; Maria C P Batitucci; Flavia de Paula
Journal:  Mol Biol Rep       Date:  2014-10-31       Impact factor: 2.316

4.  The Landscape of Clinical Implementation of Pharmacogenetic Testing in Central China: A Single-Center Study.

Authors:  Jingmin Zhang; Guangzhao Qi; Chao Han; Yubing Zhou; Yongjie Yang; Xinru Wang; Suna Liu; Xiaojian Zhang
Journal:  Pharmgenomics Pers Med       Date:  2021-12-14

Review 5.  Neuroimaging and genetic risk for Alzheimer's disease and addiction-related degenerative brain disorders.

Authors:  Florence F Roussotte; Madelaine Daianu; Neda Jahanshad; Cassandra D Leonardo; Paul M Thompson
Journal:  Brain Imaging Behav       Date:  2014-06       Impact factor: 3.978

6.  Genetic influence of plasma homocysteine on Alzheimer's disease.

Authors:  Tina Roostaei; Daniel Felsky; Arash Nazeri; Philip L De Jager; Julie A Schneider; David A Bennett; Aristotle N Voineskos
Journal:  Neurobiol Aging       Date:  2017-10-13       Impact factor: 4.673

Review 7.  Pathology supported genetic testing and treatment of cardiovascular disease in middle age for prevention of Alzheimer's disease.

Authors:  Maritha J Kotze; Susan J van Rensburg
Journal:  Metab Brain Dis       Date:  2012-04-19       Impact factor: 3.584

8.  Correlation of homocysteine metabolic enzymes gene polymorphism and mild cognitive impairment in the Xinjiang Uygur population.

Authors:  Mei Luo; Huihui Ji; Xiaohui Zhou; Jie Liang; Ting Zou
Journal:  Med Sci Monit       Date:  2015-01-27

9.  Application of artificial neural networks to investigate one-carbon metabolism in Alzheimer's disease and healthy matched individuals.

Authors:  Fabio Coppedè; Enzo Grossi; Massimo Buscema; Lucia Migliore
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

Review 10.  Protein phosphatase 2A dysfunction in Alzheimer's disease.

Authors:  Jean-Marie Sontag; Estelle Sontag
Journal:  Front Mol Neurosci       Date:  2014-03-11       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.